Skip to main content

Table 5 Perioperative outcomes in converted cases

From: Laparoscopic cholecystectomy during the COVID-19 pandemic in a tertiary care hospital in Germany: higher rates of acute and gangrenous cholecystitis in elderly patients

 

Control group n (%) or mean (SD)

Pandemic group n (%) or mean (SD)

p value

Total

Total (n)

10 (50.0)

10 (50.0)

 

20 (100.0)

Sex

   Male

8 (80.0)

9 (90.0)

1.000

17 (85.0)

   Female

2 (20.0)

1 (10.0)

3 (15.0)

Age; years

69.9 (9.4)

67.3 (7.3)

0.684

68.6 (8.3)

Cholecystitis

10 (100.0)

10 (100.0)

 

20 (100.0)

Gangrenous cholecystitis

4 (40.0)

3 (30.0)

1.000

7 (35.0)

Biliary pancreatitis

1 (10.0)

1 (10.0)

1.000

2 (10.0)

Early cholecystectomy

8 (80.0)

6 (60.0)

0.628

14 (70.0)

Operation time; min

138.9 (54.5)

152.2 (64.4)

0.912

145.6 (58.5)

IBL; ml

333.3 (510.5)

235.0 (122.6)

0.356

281.6 (354.8)

LOS; days

11.5 (9.2)

7.9 (2.5)

0.739

9.7 (6.8)

Overall morbidity

2 (20.0)

3 (30.0)

1.000

5 (25.0)

30-day mortality

0 (0.0)

0 (0.0)

 

0 (0.0)

Postoperative complications

 Wound infection (CD 1)

1 (10.0)

1 (10.0)

0.547

2 (10.0)

 Wound hematoma (CD 1)

0 (0.0)

1 (10.0)

1 (5.0)

 Postoperative pneumonia (CD 2)

0 (0.0)

1 (10.0)

1 (5.0)

 Iatrogenic bile duct injury (CD IIIb)

1 (10.0)

0 (0.0)

1 (5.0)

 Total

2 (20.0)

3 (30.0)

5 (25.0)

Reason for conversion

 Massive inflammatory adhesions

4 (40.0)

6 (60.0)

0.315

10 (50.0)

 Dissection difficulties

3 (30.0)

4 (40.0)

7 (35.0)

 Bleeding

2 (20.0)

0 (0.0)

2 (10.0)

 Ventilation difficulties

1 (10.0)

0 (0.0)

1 (5.0)

 Total

10 (100.0)

10 (100.0)

20 (100.0)

  1. CD Clavien-Dindo, IBL intraoperative blood loss, LOS length of stay, SD standard deviation